Scinai Stock Surges on $2.61 Million Private Placement as SCNI Bets on CDMO Expansion
Shares of Scinai Immunotherapeutics Ltd. surged Friday in U.S. trading, buoyed by news out of Jerusalem: the biotech secured a $2.61 million private placement plus a warrant inducement to help bankroll its contract drug-manufacturing expansion and targeted immunotherapy programs. The company's American Depositary Shares on Nasdaq soared roughly 82% to $0.8299, after peaking at $1.11 earlier.
Company hubNASDAQ:SCNI
Scinai (SCNI) Stock News & Analysis
Follow the latest Scinai (SCNI) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
TechStock² Updates
